Delta Research Partners, Llc

Bastrop, Louisiana 71220

0 studies enrolling now · 9 studies all time

What they study most

Hepatitis C, Chronic, Irritable Bowel Syndrome Characterized by Constipation, Liver Cirrhosis, Non-alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis (NASH), Nonalcoholic Fatty Liver Disease (NAFLD), Nonalcoholic Steatohepatitis, Nonalcoholic Steatohepatitis (NASH), Osteoarthritis

Studies at this site

• A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3) — Completed
• Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH) — Completed
• AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH) — Stopped early
• Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis — Stopped early
• Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) — Completed
• Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis — Stopped early
• The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) — Completed
• Gilead Sustained Virologic Response (SVR) Registry — Completed
• Rates of Gastric Ulcer by Endoscopy in Knee Osteoarthritis Patients Receiving LT-NS001 Versus Naprosyn® — Completed